Betapace AF en es it fr

Betapace AF Brand names, Betapace AF Analogs

Betapace AF Brand Names Mixture

  • No information avaliable

Betapace AF Chemical_Formula


Betapace AF RX_link

Betapace AF fda sheet

Betapace AF msds (material safety sheet)

Betapace_AF MSDS

Betapace AF Synthesis Reference

No information avaliable

Betapace AF Molecular Weight

1599.14 g/mol

Betapace AF Melting Point

No information avaliable

Betapace AF H2O Solubility

Insoluble in cold water

Betapace AF State


Betapace AF LogP

No information avaliable

Betapace AF Dosage Forms

Suspension; Tablet for oral administration (1g)

Betapace AF Indication

For the short-term treatment (up to 8 weeks) of active duodenal ulcer. Also used as maintenance therapy for duodenal ulcer patients at reduced dosage (1 gram twice a day) after healing of acute ulcers.

Betapace AF Pharmacology

Sucralfate is a prescription medication used to treat peptic ulcers. The current clinical uses of sucralfate are limited. It is effective for the healing of duodenal ulcers, but it is not frequently used for this since more effective drugs (e.g. proton pump inhibitors) have been developed. Although the mechanism of sucralfate's ability to accelerate healing of duodenal ulcers remains to be fully defined, it is known that it exerts its effect through a local, rather than systemic, action. Chemically, sucralfate is a complex of the disaccharide sugar, sucrose, combined with sulfate and aluminum. In acidic solutions (e.g. gastric acid) it forms a thick paste that has a strong negative charge.

Betapace AF Absorption

Minimally absorbed from the gastrointestinal tract (up to 5% of the disaccharide component and less than 0.02% of aluminum).

Betapace AF side effects and Toxicity

Acute oral toxicity (LD50) in mice is >8000 mg/kg. There is limited experience in humans with overdosage of sucralfate. Sucralfate is only minimally absorbed from the gastrointestinal tract and thus risks associated with acute overdosage should be minimal. In rare reports describing sucralfate overdose, most patients remained asymptomatic.

Betapace AF Patient Information

Betapace AF Organisms Affected

Humans and other mammals